FIELD: medicine.
SUBSTANCE: according to the first version, method includes extraction of allogenic mesenchymal stem cells culture from umbilical cord of newborn after normal delivery for their parenteral introduction in patient according to specified technology. According to the second version, method includes extraction of allogenic mesenchymal stem cells culture from placenta of newborn after normal delivery for their parenteral introduction in patient according to the same technology. The first and second preparations contain the following amount of allogenic mesenchymal stem cells in sterile physiological solution - in the range from 1 to 5 million cells in 5 ml of solution.
EFFECT: increase of therapeutical effect.
6 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING OF BIOSAFE CULTURE OF MESENCHIMAL STEM CELLS FROM HUMAN CHORIONIC VILLAE | 2016 |
|
RU2645255C1 |
| METHOD FOR OBTAINING BIOSAFE CULTURE OF MESENCHYMAL STEM CELLS FROM GELATIN OF WHARTON OF HUMAN UMBILICAL CORD | 2016 |
|
RU2674344C2 |
| CELL PRODUCT FOR AUTO- AND ALLOGRAFTING PREPARED OF HUMAN UMBILICAL CORD, AND METHOD FOR PREPARING THEREOF | 2011 |
|
RU2455357C1 |
| CELL PRODUCT FOR AUTO- AND ALLOGRAFTING PREPARED OF HUMAN UMBILICAL CORD, AND METHOD FOR PREPARING THEREOF | 2011 |
|
RU2455353C1 |
| METHOD FOR PREPARING CELL MATERIAL FROM HUMAN PLACENTA | 2015 |
|
RU2599418C1 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
| AMYOTROPHIC LATERAL SCLEROSIS TREATMENT USING CELLS OBTAINED FROM UMBILICAL CORD | 2012 |
|
RU2612391C2 |
| METHOD OF TREATMENT OF ISCHEMIC ANGIOPATHY OF LOWER EXTREMITY VESSELS | 2017 |
|
RU2649498C1 |
| BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
